The US share of global life sciences venture capital rose to 67% in Q4 2024, up from 59% in 2023.
CRE Herald
Unlock Unlimited CRE Intelligence
Market analysis, deal insights, and sector research trusted by fund managers, asset managers, and senior executives.
Already s subscriber? Log in to unlock this content
